Total Payments
$34,159
2024 Payments
$12,721
Companies
22
Transactions
136
Medicare Patients
14,943
Medicare Billing
$15.4M
Payment Breakdown by Category
Consulting$26,443 (77.4%)
Food & Beverage$4,357 (12.8%)
Travel$1,847 (5.4%)
Gifts$1,459 (4.3%)
Education$52.66 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $26,443 | 7 | 77.4% |
| Food and Beverage | $4,357 | 121 | 12.8% |
| Travel and Lodging | $1,847 | 5 | 5.4% |
| Gift | $1,459 | 1 | 4.3% |
| Education | $52.66 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $13,807 | 15 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $10,000 | 2 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $4,718 | 17 | $0 (2024) |
| Carl Zeiss Meditec, Inc. | $1,459 | 1 | $0 (2020) |
| Genentech USA, Inc. | $1,303 | 36 | $0 (2024) |
| Genentech, Inc. | $756.92 | 4 | $0 (2018) |
| Apellis Pharmaceuticals, Inc. | $480.66 | 8 | $0 (2024) |
| Horizon Therapeutics plc | $266.25 | 15 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $255.96 | 5 | $0 (2021) |
| Coherus Biosciences Inc. | $178.51 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,721 | 36 | Amgen Inc. ($11,807) |
| 2023 | $2,839 | 25 | Amgen Inc. ($2,000) |
| 2022 | $307.76 | 14 | Genentech USA, Inc. ($76.82) |
| 2021 | $546.67 | 12 | Genentech USA, Inc. ($274.98) |
| 2020 | $1,518 | 4 | Carl Zeiss Meditec, Inc. ($1,459) |
| 2019 | $89.70 | 5 | Horizon Therapeutics plc ($34.39) |
| 2018 | $5,749 | 24 | Regeneron Healthcare Solutions, Inc. ($4,293) |
| 2017 | $10,386 | 16 | Regeneron Pharmaceuticals, Inc. ($10,000) |
All Payment Transactions
136 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: OPTOMETRY | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $35.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/11/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Ophthalmology | ||||||
| 10/04/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $216.49 | General |
| Category: Ophthalmology | ||||||
| 10/01/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: EYE CARE | ||||||
| 09/30/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Ophthalmology | ||||||
| 09/03/2024 | Harrow Eye, LLC | IHEEZO (Drug), TRIESENCE | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: OPTOMETRY | ||||||
| 08/26/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: Ophthalmology | ||||||
| 08/23/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/22/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $89.49 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 07/17/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Ophthalmology | ||||||
| 07/08/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/21/2024 | Amgen Inc. | PAVBLU (Biological) | Consulting Fee | Cash or cash equivalent | $5,362.50 | General |
| Category: Inflammation | ||||||
| 06/21/2024 | Amgen Inc. | PAVBLU (Biological) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Inflammation | ||||||
| 06/21/2024 | Amgen Inc. | PAVBLU (Biological) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Inflammation | ||||||
| 06/21/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Ophthalmology | ||||||
| 06/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $121.79 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/12/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: Ophthalmology | ||||||
| 05/17/2024 | Amgen Inc. | — | Travel and Lodging | In-kind items and services | $198.18 | General |
| 05/17/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $18.73 | General |
| 05/17/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $16.42 | General |
| 05/17/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $5.24 | General |
| 05/16/2024 | Amgen Inc. | — | Travel and Lodging | In-kind items and services | $664.60 | General |
| 05/16/2024 | Amgen Inc. | — | Travel and Lodging | In-kind items and services | $263.54 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 3,770 | 24,370 | $14.0M | $4.0M |
| 2022 | 19 | 3,833 | 16,830 | $13.1M | $3.8M |
| 2021 | 19 | 3,698 | 15,405 | $12.0M | $3.7M |
| 2020 | 18 | 3,642 | 16,470 | $11.7M | $3.8M |
Total Patients
14,943
Total Services
73,075
Medicare Billing
$15.4M
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 268 | 3,026 | $6.8M | $2.1M | 30.7% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 109 | 2,252 | $1.1M | $489,118 | 43.4% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 75 | 1,696 | $847,500 | $311,152 | 36.7% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 31 | 8,340 | $695,056 | $242,645 | 34.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 1,007 | 2,615 | $523,000 | $230,766 | 44.1% |
| 67028 | Injection of drug into eye | Office | 2023 | 479 | 2,152 | $2.5M | $204,164 | 8.3% |
| J3490 | Unclassified drugs | Office | 2023 | 27 | 58 | $336,400 | $114,502 | 34.0% |
| 92134 | Imaging of retina | Office | 2023 | 1,141 | 3,355 | $335,386 | $103,293 | 30.8% |
| J3590 | Unclassified biologics | Office | 2023 | 30 | 54 | $153,000 | $65,440 | 42.8% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 40 | 40 | $228,000 | $35,661 | 15.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 255 | 255 | $71,400 | $28,835 | 40.4% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 18 | 175 | $75,002 | $27,765 | 37.0% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 19 | 19 | $114,000 | $17,725 | 15.5% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 21 | 22 | $88,000 | $15,429 | 17.5% |
| 67039 | Destruction of eye fluid (vitreous) between lens and retina using a laser | Facility | 2023 | 13 | 13 | $62,400 | $9,895 | 15.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 53 | 53 | $15,105 | $5,690 | 37.7% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 23 | 69 | $11,850 | $5,131 | 43.3% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 14 | 15 | $22,500 | $2,681 | 11.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 31 | 32 | $6,400 | $2,185 | 34.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 22 | 30 | $4,500 | $1,296 | 28.8% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 62 | 65 | $6,825 | $1,110 | 16.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,800 | $1,065 | 38.0% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 18 | 20 | $6,100 | $690.42 | 11.3% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 319 | 3,192 | $7.2M | $2.3M | 31.8% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 114 | 3,314 | $1.7M | $737,965 | 44.5% |
About Dr. Wayne Solley, M.D
Dr. Wayne Solley, M.D is a Ophthalmology healthcare provider based in Arlington, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528042447.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wayne Solley, M.D has received a total of $34,159 in payments from pharmaceutical and medical device companies, with $12,721 received in 2024. These payments were reported across 136 transactions from 22 companies. The most common payment nature is "Consulting Fee" ($26,443).
As a Medicare-enrolled provider, Solley has provided services to 14,943 Medicare beneficiaries, totaling 73,075 services with total Medicare billing of $15.4M. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Arlington, TX
- Active Since 12/05/2005
- Last Updated 12/01/2011
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1528042447
Products in Payments
- EYLEA AFLIBERCEPT INJECTION (Biological) $14,326
- PAVBLU (Biological) $10,363
- CLARUS (Device) $1,459
- Lucentis (Biological) $989.40
- Non-Covered Product (Drug) $606.37
- Syfovre (Drug) $480.66
- SUSVIMO (Drug) $290.49
- TEPEZZA (Drug) $231.86
- EYLEA (Biological) $206.95
- Cimerli (Biological) $203.15
- OZURDEX (Drug) $198.62
- EYLEA HD (Biological) $185.77
- YUTIQ (Drug) $177.45
- Izervay (Drug) $165.70
- BEOVU (Drug) $161.36
- Vabysmo (Drug) $121.59
- DEXTENZA (Drug) $89.49
- TEPEZZA (Biological) $70.14
- IHEEZO (Drug) $50.15
- DUREZOL (Drug) $41.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Arlington
David Callanan, M.d, M.D
Ophthalmology — Payments: $152,495
Ophthalmology $152,495
Dr. Michael Blair, M.d, M.D
Ophthalmology — Payments: $47,481
Ophthalmology $47,481
Patrick Williams, M.d, M.D
Ophthalmology — Payments: $23,051
Ophthalmology $23,051
Dr. D Ford, M.d, M.D
Ophthalmology — Payments: $17,544
Ophthalmology $17,544
Sahmon Chinichian, D.o, D.O
Ophthalmology — Payments: $15,227
Ophthalmology $15,227
Nikisha Kothari, M.d, M.D
Ophthalmology — Payments: $14,140
Ophthalmology $14,140